Barclays PLC Essa Pharma Inc. Transaction History
Barclays PLC
- $377 Billion
- Q3 2024
A detailed history of Barclays PLC transactions in Essa Pharma Inc. stock. As of the latest transaction made, Barclays PLC holds 355 shares of EPIX stock, worth $649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
355
Previous 355
-0.0%
Holding current value
$649
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding EPIX
# of Institutions
35Shares Held
35.1MCall Options Held
15.8KPut Options Held
21K-
Bvf Inc San Francisco, CA8.75MShares$16 Million1.69% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.88MShares$14.4 Million0.8% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.29MShares$7.85 Million2.21% of portfolio
-
Morgan Stanley New York, NY4.18MShares$7.65 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$5.97 Million0.32% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $80.7M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...